Emeishan Longteng Biotechnology

Emeishan Longteng Biotechnology is a specialized biopharmaceutical company focused on the research, development, and large-scale production of urinary-derived hormones and enzymes. Established in 2005 and headquartered in Sichuan, China, the company has become a significant global supplier of Active Pharmaceutical Ingredients (APIs) such as Human Chorionic Gonadotropin (HCG), Human Menopausal Gonadotropin (HMG), and Urokinase. Their manufacturing processes emphasize high-purity extraction from natural sources, adhering to international GMP standards to serve the reproductive health and cardiovascular therapeutic sectors. The company maintains a strong presence in both the Chinese domestic market and various international export markets.